Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.827 | 0.160 | 4 | 186079102 | intron variant | C/T | snv | 0.14 |
|
Skin and Connective Tissue Diseases; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.827 | 0.160 | 4 | 186079102 | intron variant | C/T | snv | 0.14 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.160 | 4 | 186079102 | intron variant | C/T | snv | 0.14 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.160 | 4 | 186079102 | intron variant | C/T | snv | 0.14 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.160 | 4 | 186079102 | intron variant | C/T | snv | 0.14 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.160 | 4 | 186079102 | intron variant | C/T | snv | 0.14 |
|
Neoplasms; Stomatognathic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.200 | 4 | 186079213 | intron variant | C/T | snv | 0.19 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.200 | 4 | 186079213 | intron variant | C/T | snv | 0.19 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.851 | 0.200 | 4 | 186079213 | intron variant | C/T | snv | 0.19 |
|
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.200 | 4 | 186079213 | intron variant | C/T | snv | 0.19 |
|
0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
0.851 | 0.160 | 4 | 186079221 | intron variant | G/C;T | snv |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.851 | 0.160 | 4 | 186079221 | intron variant | G/C;T | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.851 | 0.160 | 4 | 186079221 | intron variant | G/C;T | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.851 | 0.160 | 4 | 186079221 | intron variant | G/C;T | snv |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.851 | 0.160 | 4 | 186079221 | intron variant | G/C;T | snv |
|
Pathological Conditions, Signs and Symptoms; Digestive System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.080 | 4 | 186079262 | intron variant | C/A;T | snv |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
4 | 186072885 | intron variant | G/A | snv | 0.21 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||||
|
4 | 186072885 | intron variant | G/A | snv | 0.21 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 4 | 186080138 | intron variant | C/A;T | snv |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 4 | 186080138 | intron variant | C/A;T | snv |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||||
|
1.000 | 4 | 186080138 | intron variant | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||||
|
1.000 | 4 | 186080138 | intron variant | C/A;T | snv |
|
0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||||
|
1.000 | 0.080 | 4 | 186079310 | intron variant | A/G | snv | 4.0E-02 |
|
Digestive System Diseases; Infections | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 4 | 186083922 | stop gained | G/T | snv |
|
0.700 | 0 | |||||||||||||
|
4 | 186076620 | start lost | A/G | snv | 4.0E-06 | 7.0E-06 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 |